Dilfuza Kurbanbekova

A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine

B. Winikoff, I. Platais, Tamar Tsereteli, 2019, BMJ Sexual & Reproductive Health.

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

B. Winikoff, S. Raghavan, A. Kamilov, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.

B. Winikoff, I. Platais, R. Comendant, 2015, Contraception.